|Capital stock||4,449,844,000 yen|
|Common shares authorized||44,000,000 shares|
|Common shares issued||22,547,140 shares （including 152,884 treasury shares）|
|Stock exchange listings||Tokyo Stock Exchange Prime Section|
|Stock trading unit||100 shares|
|Shareholders||10,392 （increase of 164 since the end of the previous fiscal year）|
|Shareholder name||Number of shares held (shares)||Percentage of total shares outstanding|
|Nippon Suisan Kaisha, Ltd.||12,106,202||54.1|
|The Master Trust Bank of Japan, Ltd. (Trust Account)||918,400||4.1|
|Custody Bank of Japan, Ltd.(Trust Account)||631,800||2.8|
|Nissui Logistics Corporation||273,053||1.2|
|Nissui Pharmaceutical Minori Shareholders’ Association||207,754||0.9|
|Nissui Pharmaceutical Directors Shareholders’ Association||124,780||0.6|
|Sompo Japan Nipponkoa Insurance Inc.||99,800||0.4|
|Mitsubishi UFJ Morgan Stanley Securities Ltd.||95,300||0.4|
Note: The Company is holding 152,884 treasury shares (0.7% of total shares issued), but is not included in the above list of major shareholders.
At present, Nissui Pharmaceutical is not included in any stock indices.
At present, Nissui Pharmaceutical has no outstanding bonds and has not obtained a credit rating.
At present, Nissui Pharmaceutical has no history of having engaged in share or capital transfers.